HomeIMMNOV • STO
add
Immunovia AB (publ)
Previous close
kr 0.64
Day range
kr 0.62 - kr 0.65
Year range
kr 0.24 - kr 1.31
Market cap
194.36M SEK
Avg Volume
10.57M
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 90.00K | 5.88% |
Operating expense | 20.15M | -16.69% |
Net income | -41.05M | -60.37% |
Net profit margin | -45.61K | -51.46% |
Earnings per share | -0.14 | — |
EBITDA | -19.74M | 12.29% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 29.27M | -20.37% |
Total assets | 34.85M | -40.19% |
Total liabilities | 17.11M | -55.64% |
Total equity | 17.74M | — |
Shares outstanding | 306.08M | — |
Price to book | 10.67 | — |
Return on assets | -127.54% | — |
Return on capital | -210.79% | — |
Cash Flow
Net change in cash
(SEK) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -41.05M | -60.37% |
Cash from operations | -18.14M | 32.07% |
Cash from investing | — | — |
Cash from financing | 10.01M | -18.94% |
Net change in cash | -8.40M | 41.76% |
Free cash flow | -22.82M | -557.61% |
About
Founded
2007
Website
Employees
8